Drug-labels.com

Micro Mn: Uses, Side Effects and Dosage

Updated:
Strength:
0.1 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Micro Mn

What is MICRO MN used for?

MICRO MN is used with other nutrition products that are given to you through an infusion into your vein. It is given to you when you cannot eat normally. It helps maintain normal levels of the nutrient manganese in your blood.

How does MICRO MN work?

Manganese is an essential nutrient for your body. MICRO MN works by maintaining normal levels of manganese in your blood. This helps prevent problems when manganese levels are low.

What are the ingredients in MICRO MN?

Medicinal ingredient: manganese (as manganese sulfate monohydrate).

Non-medicinal ingredients: sulfuric acid, water for injection.

MICRO MN comes in the following dosage form: solution, 0.1 mg/mL

Do not use MICRO MN if you:

  • are allergic to manganese or to any of the other ingredients of MICRO MN or to a component of the container.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take MICRO MN. Talk about any health conditions or problems you may have, including if you:

  • have a liver condition where there is a blockage of the bile duct.
  • are pregnant or plan to become pregnant.

  • are breastfeeding or plan to breastfeed. It is not known if MICRO MN passes into breast milk.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

There are no known relevant interactions at this time.

How to take MICRO MN:

  • MICRO MN will be given to you into your vein by a healthcare professional.
  • Your healthcare professional will make sure that MICRO MN is prepared correctly before it is given to you.
  • Your healthcare professional will routinely monitor the nutrient levels in your blood.

Usual dose:

Your healthcare professional will decide on the actual dose of MICRO MN that is right for you based on your age, body weight, and medical condition.

Overdose:

What are possible side effects from using MICRO MN?

There are no known side effects at this time. If you experience any side effects, tell your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting ( https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html ) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Your healthcare professional will store MICRO MN at 15 - 28°C. Protect from freezing.

Keep out of sight and reach of children.

If you want more information about MICRO MN:

  • Talk to your healthcare professional.
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (https://health-products.canada.ca/dpd-bdpp/index-eng.jsp); the manufacturer’s website www.sandoz.ca or by calling 1-800-361-3062.

Revised on: JAN 19, 2022

If you think you, or a person you are caring for, have taken too much MICRO MN, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 00786942

Revision date stated in the text: January 19, 2022

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Micro Mn

DIN 00786942
Schedule(s) ETHICAL
Active ingredient(s) Manganese (manganese sulfate) 0.1 MG
Dosage form(s) Solution
Route(s) of administration Intravenous
Company SANDOZ CANADA INCORPORATED
Current status Marketed
Current status date July 29, 2006

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.